To Evaluate the Effects of NMRA-335140 on Symptoms of Major Depression in Participants With Bipolar II Disorder.

NCT06429722 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Episode Associated With Bipolar II Disorder

Interventions

DRUG: NMRA-335140 80 mg
DRUG: Placebo

Sponsor

Neumora Therapeutics, Inc.